Piper Sandler Maintains Regeneron at Overweight, Raises Target to $865
Piper Sandler raised its price target to $865 per share from $854 while maintaining its Overweight rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.